ERBB2 and breast cancer: However, cGAS-STING scores were significantly higher in TNBCs, basal-like and HER2-enriched breast cancer subtypes, both in the TCGA (P < 0.001, Fig. 1l, m) and METABRIC cohorts (P < 0.001, Fig. 1n, o).